What is the next best step in managing a patient with persistent first metatarsophalangeal joint pain suspected gout, who failed indomethacin, had a 5‑day course of prednisone 35 mg orally daily with partial improvement but pain recurred after taper, and a normal X‑ray?

Confirm the Diagnosis with Synovial Fluid Analysis or Ultrasound

The next best step is to obtain definitive diagnosis through joint aspiration with synovial fluid analysis for monosodium urate crystals under polarized light microscopy, or if aspiration is unsuccessful or not feasible, perform point-of-care ultrasound to look for characteristic gout findings (double contour sign, hyperechoic intra-articular deposits). 1, 2, 3, 4

Why Diagnostic Confirmation is Critical Now

You have a patient with persistent 1st MTP pain who has failed standard acute gout treatment and experienced symptom recurrence after steroid taper. This clinical picture raises three critical possibilities:

• True gout with inadequate treatment duration or dosing
• Alternative diagnosis masquerading as gout (septic arthritis, seronegative inflammatory arthritis, sesamoiditis)
• Chronic tophaceous gout requiring different management

The normal X-ray does not rule out gout—ultrasound is far more sensitive for detecting erosions and tophi 5. The recurrence after stopping prednisone suggests either ongoing crystal-induced inflammation or an entirely different inflammatory process.

Diagnostic Approach

First-Line: Joint Aspiration

• Aspirate the 1st MTP joint and examine synovial fluid under polarized light microscopy for needle-shaped, negatively birefringent monosodium urate crystals 4
• This is the gold standard for definitive gout diagnosis
• Simultaneously send fluid for cell count, Gram stain, and culture to exclude septic arthritis
• Common pitfall: If aspiration yields a "dry tap" due to viscous chalky material, this actually suggests chronic tophaceous gout 3

If Aspiration Fails or is Not Feasible: Point-of-Care Ultrasound

Look for these characteristic findings 5, 3:

• Double contour sign (hyperechoic band over articular cartilage)
• Diffuse hyperechoic intra-articular deposits
• Joint effusion
• Synovial hypertrophy
• Tophus-like lesions
• Erosions (more sensitive than X-ray)
• Increased power Doppler signal (indicates active inflammation)

Management Based on Diagnostic Findings

If Gout is Confirmed:

For the Current Flare: Your prednisone course was too short. The 2012 ACR guidelines recommend 2:

• Prednisone 0.5 mg/kg/day for 5-10 days at full dose then stop OR
• 2-5 days at full dose then taper for 7-10 days then stop

You gave 35 mg daily for 5 days without taper—this explains the rebound. Restart prednisone at 35 mg daily and taper over 7-10 days 1, 2.

Alternatively, consider:

• Colchicine 1.2 mg followed by 0.6 mg one hour later (if started within 36 hours of symptom onset) 1
• Combination therapy for severe/persistent symptoms: oral corticosteroids + colchicine 2
• Ultrasound-guided intra-articular corticosteroid injection (20 mg triamcinolone) if single joint involvement—highly effective with rapid pain relief 5

Initiate Urate-Lowering Therapy (ULT): This patient has recurrent gout (multiple treatment courses needed), which is a clear indication to start ULT 1, 6, 7:

1. Start allopurinol 100 mg daily (first-line agent) 7
2. Titrate by 100 mg every 2-4 weeks to achieve serum uric acid <6 mg/dL 6, 1
3. Concurrent anti-inflammatory prophylaxis is mandatory when starting ULT 7:
   • Colchicine 0.6 mg once or twice daily, OR
   • Low-dose NSAID (naproxen 250 mg twice daily) with PPI, OR
   • Low-dose prednisone (<10 mg/day)
4. Continue prophylaxis for at least 6 months 2, 6, 7

Critical point: You can start ULT during an active flare—there is no need to wait for complete resolution 7.

If Gout is NOT Confirmed:

Consider alternative diagnoses:

• Septic arthritis (requires urgent drainage and antibiotics)
• Seronegative inflammatory arthritis (psoriatic, reactive)
• Sesamoiditis or other mechanical pathology 8
• Functional hallux limitus

Each requires completely different management, making diagnostic confirmation essential before proceeding.

Common Pitfalls to Avoid

1. Don't assume gout based on hyperuricemia alone—up to 30% of acute gout patients have normal serum uric acid during flares 9
2. Don't start ULT without anti-inflammatory prophylaxis—this will precipitate more flares 7
3. Don't use short steroid courses without taper—rebound inflammation is predictable 10
4. Don't delay ULT in recurrent gout—this patient already qualifies for long-term management 1, 6